Skip to content

Boston Beer SAM Granted (in dollars per share)

Granted (in dollars per share) at other companies

CHE
ChemedCHE
514.4-8.8%
DJT
Trump Media & Technology GroupDJT
$0.00
Belden logo
BeldenBDC
$120.25+33.6%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$101.14
General Motors logo
General MotorsGM
$50.88+21.8%
Accenture logo
AccentureACN
$346.49+1.4%

Other financials

Income statement

See full
Revenue$433.9M-4.4%
Gross profit$214.0M-2.4%
Operating income-$190.5M-664%
Net income-$145.3M-695%
EPS (diluted)-$13.88-743%

Balance sheet

See full
Cash & equivalents$164.1M+7.7%
Total debt$34.7M-25.8%
Total equity$682.6M-23.9%
Total assets$1.2B-5.6%

Cash flow

See full
Operating cash flow-$20.4M-1,154%
CapEx$12.3M+24.2%
Free cash flow-$32.8M-310%

Valuation

See full
Market cap$1.88B-10.4%
Enterprise value$1.75B-11.7%
P/S-0.1×

Profitability

See full
Gross margin48.7%+3.3pp
Operating margin5.7%
Net margin4.6%
FCF margin9.8%+0.7pp

Returns & leverage

See full
Return on equity10.2%
Debt / equity0.1×0.0×
Current ratio0.9×-0.8×

Where this comes from

Reported directly by Boston Beer in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: Boston Beer’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Beer's granted (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Beer's granted (in dollars per share)?
Boston Beer (SAM) reported granted (in dollars per share) of $210.34 in Q1 2026.
How has Boston Beer's granted (in dollars per share) changed year-over-year?
Boston Beer's granted (in dollars per share) decreased by 10.1% year-over-year, from $234.06 to $210.34.
What does granted (in dollars per share) mean?
The weighted average fair value at the grant date for non-option equity awards issued during the period. This figure provides insight into the cost basis of equity-based compensation and the market's valuation of the company's long-term incentive programs.